Home > Financial Ratios > NGL FINECHEM

NGL FINECHEM
EBIT Growth

    Back to All Ratios
NGL FINECHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year EBIT Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EBIT Growth(%) 121.16-44.9292.58-57.38-14.14

What is the latest EBIT Growth ratio of NGL FINECHEM ?

The latest EBIT Growth ratio of NGL FINECHEM is 121.16 based on Mar2026 Consolidated results.
Year EBIT Growth
Mar2026121.16
Mar2025-44.92
Mar202492.58
Mar2023-57.38
Mar2022-14.14

How is EBIT Growth of NGL FINECHEM Trending?

Years EBIT Growth % Change
Mar2026 121.16
Positive
Mar2025 -44.92
Negative
Mar2024 92.58
Positive
Mar2023 -57.38
Negative
Mar2022 -14.14 -

Other Financial Ratios of NGL FINECHEM


Compare EBIT Growth ratio of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹1,813.9 Cr -2.8% 4.4% 106.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,539.0 Cr -1.4% -6.6% 7.3% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 1.2% -2.6% 60% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,251.0 Cr -2% -6.1% 33% Stock Analytics
CIPLA ₹105,290.0 Cr -2.3% -5.8% -13.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,752.6 Cr -1.1% 3.8% -5.5% Stock Analytics


NGL FINECHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

-2.8%

4.4%

106.1%

SENSEX

0.8%

-4.8%

-10.5%


You may also like the below Video Courses